Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Translate Bio's Total Stockholders Equity for the quarter that ended in Jun. 2021 was $412.6 Mil. Translate Bio's Total Assets for the quarter that ended in Jun. 2021 was $904.9 Mil.
Therefore, Translate Bio's Equity to Asset Ratio for the quarter that ended in Jun. 2021 was 0.46.
The historical rank and industry rank for Translate Bio's Equity-to-Asset or its related term are showing as below:
TBIO'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.83 Med: 0.43 Max: 0.6
Current: 0.46
During the past 5 years, the highest Equity to Asset Ratio of Translate Bio was 0.60. The lowest was -0.83. And the median was 0.43.
TBIO's Equity-to-Asset is not ranked
in the Biotechnology industry.
Industry Median: 0.67
vs TBIO: 0.46
Translate Bio Equity-to-Asset Historical Data
The historical data trend for Translate Bio's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Translate Bio's Equity-to-Asset
For the Biotechnology subindustry, Translate Bio's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Translate Bio's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Translate Bio's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Translate Bio's Equity-to-Asset falls into.
Translate Bio Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Translate Bio's Equity to Asset Ratio for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Translate Bio (NAS:TBIO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Translate Bio Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Translate Bio's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Translate Bio (Translate Bio) Business Description
Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TBIO has been successfully added to your 